Announcements
October 11, 2021

Tachinardi named interim president and CEO of Regenstrief Institute

Umberto Tachinardi, M.D., will serve as interim president and chief executive officer of the Regenstrief Institute, effective December 6, 2021.

As Chief Information Officer, Dr. Tachinardi is part of the Institute’s senior leadership team and also is a research scientist with the Clem McDonald Center for Biomedical Informatics at Regenstrief.

He is a professor at the Department of Biostatistics and Health Data Science and assistant dean for Clinical Informatics for the Indiana University School of Medicine and is the director of Informatics for the Indiana Clinical and Translational Sciences Institute.

He has worked in the rapidly growing field of informatics for more than 30 years. He came to Regenstrief and IU School of Medicine in 2019 from the School of Medicine and Public Health, University of Wisconsin-Madison, where he served in various leadership positions in biomedical informatics and translational research. He also participated in the creation of UWHealth’s enterprise analytics group. Additionally, Dr. Tachinardi served in leadership posts with the University of Chicago, for the Secretary of Health of the State of Sao Paulo, Brazil and the Heart Institute of Sao Paulo University Medical School.

Dr. Tachinardi’s appointment follows the recent announcement that Peter Embí, M.D., current Regenstrief president and CEO, is departing later this year to chair Vanderbilt University Medical Center’s Department of Biomedical Informatics. Dr. Embí will also will serve as senior vice president for research and innovation, a newly created position.

  • Umberto Tachinardi, Regenstrief Institute

Related News

infographic showing findings of study

Examining how insurance coverage shapes access to kidney transplantation

Regenstrief researchers contribute to a national study highlighting differences between Medicare Advantage and traditional Medicare  For people with kidney

Tarik Yuce, MD, Jiang Bian, PhD, Serena Guo, MD, PhD, Xing He, PhD, Yu Huang, PhD

GLP-1 medications linked to greater loss of regained weight after bariatric surgery

Study involving Regenstrief researchers uses real-world evidence to evaluate an option for managing weight recurrence  People who regain weight

image of a doctor consulting with a patient

Scalable approach could improve early detection of cognitive impairment in primary care

Regenstrief-led study evaluates how existing health data and patient-reported information could help clinicians identify individuals who need further assessmentEarly

Christopher Callahan, MD

Regenstrief Institute scientist named next president and CEO of Regenstrief Foundation 

Longtime Regenstrief investigator and former IU Center for Aging Research director will assume Foundation leadership in summer 2027.  Christopher